Houston Medical Center Home
  • About our Organization
  • Commitment to Quality
  • Services
  • Health Information
  • Patient Information
  • Patient Financial Services
  • Careers & Benefits
  • Community Education
  • Physician Directory
  • Online Nursery
  • News
  • Contact Us
  • HHC Access

Health News Health Library Health Topics Healthy Living
Today's Headlines    Health Alerts    Health News Feature    Future of Medicine
Health Observances    Product Recalls
Illnesses & Conditions    Drug Guide    FDA Drug Approvals    Medical Tests    
Self-Help Resources
   Complementary Medicine    Medline Search
Allergies    Asthma    Back Pain    Cancer    Caregiver    Depression    Diabetes
Digestive Disorders    Heart Disease    Kidney Disease
Men's Health
   Pregnancy    Senior's Health    Stress    Stroke    Women's Health
Fitness   Nutrition   Mind & Body   Family & Home





Today's Headlines

Health News
Daily articles from HealthDay News: breaking news on health issues, drug approvals and recent discoveries.

Morphine Sulfate Solution Approved


For acute and chronic pain

TUESDAY, Jan. 26 (HealthDay News) -- Morphine Sulfate Oral Solution has been approved by the U.S. Food and Drug Administration to treat acute and chronic pain. Sanctioned doses are 100 milligrams per 5 mL and 20 milligrams per 1 mL, the agency said in a news release.

Although the drug has been prescribed for this use "for many years," the agency said, this form and concentration hadn't been approved until now.

The painkiller was sanctioned as part of the agency's unapproved drug initiative to "make sure marketed drugs meet current FDA standards," the news release said.

The drug is manufactured by Ohio-based Roxane Laboratories, a unit of Boehringer Ingelheim.

More information

To learn more about morphine sulfate, visit the U.S. National Institutes of Health.

Copyright © 2010 HealthDay. All rights reserved.
Health News Provided By:
HealthDay


 
© 2007 Houston Healthcare Inc., All Rights Reserved. Design and Hosting: 3W Studios